Invention Grant
- Patent Title: Heterobicyclic sphingosine 1-phosphate analogs
-
Application No.: US15621665Application Date: 2017-06-13
-
Publication No.: US10081646B2Publication Date: 2018-09-25
- Inventor: Richard D. Caldwell , Kevin M. Guckian , Gnanasambandam Kumaravel , Wen-Cherng Lee , Edward Yin-Shiang Lin , Xiaogao Liu , Bin Ma , Daniel M. Scott , Zhan Shi , Jermaine Thomas , Arthur G. Taveras , Guo Zhu Zheng
- Applicant: BIOGEN MA INC.
- Applicant Address: US MA Cambridge
- Assignee: BIOGEN MA INC.
- Current Assignee: BIOGEN MA INC.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Xin Zhang
- Main IPC: C07D239/80
- IPC: C07D239/80 ; C07F9/6512 ; C07F9/60 ; C07C217/58 ; C07C229/36 ; C07C233/47 ; C07D215/20 ; C07D263/24
Abstract:
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.
Public/Granted literature
- US20180002356A1 HETEROBICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS Public/Granted day:2018-01-04
Information query
